Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 1
Submit an article Journal homepage
324
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

IFN-γ enhances CLL cell resistance to ABT-199 by regulating MCL-1 and BCL-2 expression via the JAK-STAT3 signaling pathway

Xiaoya Shaoa School of Basic Medical Science, Henan University of Science and Technology, Luoyang, China;b Henan International Joint Laboratory of Thrombosis and Hemostasis, Luoyang, ChinaView further author information
,
Xueqiong Menga School of Basic Medical Science, Henan University of Science and Technology, Luoyang, ChinaView further author information
,
Haiping Yangc First Affiliated Hospital, Henan University of Science and Technology, Luoyang, ChinaView further author information
,
Xinxin Wanga School of Basic Medical Science, Henan University of Science and Technology, Luoyang, ChinaView further author information
,
Ling Qinc First Affiliated Hospital, Henan University of Science and Technology, Luoyang, ChinaView further author information
,
Guomin Shena School of Basic Medical Science, Henan University of Science and Technology, Luoyang, China;b Henan International Joint Laboratory of Thrombosis and Hemostasis, Luoyang, ChinaORCID Iconhttps://orcid.org/0000-0002-5006-2790View further author information
ORCID Icon,
Xiaoping Xic First Affiliated Hospital, Henan University of Science and Technology, Luoyang, ChinaView further author information
,
Huijuan Zhaoa School of Basic Medical Science, Henan University of Science and Technology, Luoyang, ChinaView further author information
,
Salvador Macipd Mechanisms of Cancer and Ageing Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester, UK;e FoodLab, Faculty of Health Sciences, Universitat Oberta de Catalunya, Barcelona, SpainView further author information
&
Yixiang Chena School of Basic Medical Science, Henan University of Science and Technology, Luoyang, China;b Henan International Joint Laboratory of Thrombosis and Hemostasis, Luoyang, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6044-1153View further author information
ORCID Icon show all
Pages 71-78 | Received 21 Mar 2022, Accepted 16 Sep 2022, Published online: 12 Oct 2022

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.